99 related articles for article (PubMed ID: 37625197)
1. Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022].
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Costes Martineau V; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2023 Oct; 8(5):101630. PubMed ID: 37625197
[No Abstract] [Full Text] [Related]
2. Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up.
van Herpen C; Vander Poorten V; Skalova A; Terhaard C; Maroldi R; van Engen A; Baujat B; Locati LD; Jensen AD; Smeele L; Hardillo J; Martineau VC; Trama A; Kinloch E; Even C; Machiels JP;
ESMO Open; 2022 Dec; 7(6):100602. PubMed ID: 36567082
[TBL] [Abstract][Full Text] [Related]
3. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.
Trama A; Licitra L; Cavalieri S; Bonfarnuzzo S; Baili P; Ciarfella A; Parente P; Almadori G; Ansarin M; Bacigalupo A; Baumeister P; Baujat B; Bossi P; Cavalera E; Cercato MC; Dieleman F; Fakhry N; Ferraresi V; Gaino F; Galizia D; Halamkova J; Halme E; Hardillo J; Hofauer B; Kinloch E; Livi L; Locati LD; Mattheis S; Mercante G; Mirabile A; Molteni G; Orlandi E; Persio R; Sciallero S; Smeele L; Tagliabue M; Valentini V; Van Harpen C; Westphalen CB; Botta L
PLoS One; 2023; 18(3):e0283071. PubMed ID: 36928072
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490].
Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;
Ann Oncol; 2023 Jul; 34(7):631. PubMed ID: 36564283
[No Abstract] [Full Text] [Related]
5. Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
Blay JY; Casali P; Ray-Coquard I; Seckl MJ; Gietema J; de Herder WW; Caplin M; Klümpen HJ; Glehen O; Wyrwicz L; Peeters R; Licitra L; Girard N; Piperno-Neumann S; Kapiteijn E; Idbaih A; Franceschi E; Trama A; Frezza AM; Hohenberger P; Hindi N; Martin-Broto J; Schell J; Rogasik M; Lejeune S; Oliver K; de Lorenzo F; Weinman A
Lancet Reg Health Eur; 2024 Apr; 39():100861. PubMed ID: 38384730
[TBL] [Abstract][Full Text] [Related]
6. 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages' in soft tissue sarcoma.
Frezza AM; Lee ATJ; Nizri E; Sbaraglia M; Jones RL; Gronchi A; Dei Tos AP; Casali PG
ESMO Open; 2018; 3(4):e000390. PubMed ID: 30018812
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Sep; 33(9):988. PubMed ID: 35810138
[No Abstract] [Full Text] [Related]
8. Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322].
Dimopoulos MA; Moreau P; Terpos E; Mateos MV; Zweegman S; Cook G; Delforge M; Hájek R; Schjesvold F; Cavo M; Goldschmidt H; Facon T; Einsele H; Boccadoro M; San-Miguel J; Sonneveld P; Mey U;
Ann Oncol; 2022 Jan; 33(1):117. PubMed ID: 34857439
[No Abstract] [Full Text] [Related]
9. Corrigendum to 'Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712].
Heuser M; Ofran Y; Boissel N; Brunet Mauri S; Craddock C; Janssen J; Wierzbowska A; Buske C;
Ann Oncol; 2021 Jun; 32(6):821. PubMed ID: 33888380
[No Abstract] [Full Text] [Related]
10. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv267. PubMed ID: 30188977
[No Abstract] [Full Text] [Related]
11. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv268-iv269. PubMed ID: 30285214
[No Abstract] [Full Text] [Related]
12. The ESMO-EURACAN-GENTURIS-ERNPaedCan Clinical Practice Guidelines for bone sarcomas - the challenges of the fight against rare cancers.
Andreou D
Ann Oncol; 2021 Dec; 32(12):1470-1471. PubMed ID: 34560241
[No Abstract] [Full Text] [Related]
13. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E; Hofer S; Brandes AA; Frappaz D; Kortmann RD; Bromberg J; Dangouloff-Ros V; Boddaert N; Hattingen E; Wiestler B; Clifford SC; Figarella-Branger D; Giangaspero F; Haberler C; Pietsch T; Pajtler KW; Pfister SM; Guzman R; Stummer W; Combs SE; Seidel C; Beier D; McCabe MG; Grotzer M; Laigle-Donadey F; Stücklin ASG; Idbaih A; Preusser M; van den Bent M; Weller M; Hau P
Lancet Oncol; 2019 Dec; 20(12):e715-e728. PubMed ID: 31797797
[TBL] [Abstract][Full Text] [Related]
14. First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN.
Morfouace M; Stevovic A; Vinches M; Golfinopoulos V; Jin DX; Holmes O; Erlich R; Fayette J; Croce S; Ray-Coquard I; Girard N; Blay JY
ESMO Open; 2020 Dec; 5(6):e001075. PubMed ID: 33262201
[TBL] [Abstract][Full Text] [Related]
15. [Special tumor entities in the head and neck region : Nasopharyngeal carcinoma, salivary gland, and thyroid cancer].
Zech HB; Betz CS
HNO; 2022 Apr; 70(4):278-286. PubMed ID: 35258645
[TBL] [Abstract][Full Text] [Related]
16. European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN.
Blay JY; Casali P; Bouvier C; Dehais C; Galloway I; Gietema J; Halámková J; Hindi N; Idbaih A; Kinloch E; Klümpen HJ; Kolarova T; Kopeckova K; Lovey J; Magalhaes M; Oselin K; Piperno-Neumann S; Ravnsbaek A; Rogasik M; Safwat A; Scheipl S; Seckl M; Taylor J; Temnyk M; Trama A; Urbonas M; Wartenberg M; Weinman A;
ESMO Open; 2021 Aug; 6(4):100174. PubMed ID: 34139485
[No Abstract] [Full Text] [Related]
17. Precision guidelines for soft tissue and visceral sarcomas: the evidence, expert experience and ensuring optimal care for rare cancers, a 2021 update from ESMO-EURACAN-GENTURIS.
Gladdy RA
Ann Oncol; 2021 Nov; 32(11):1325-1326. PubMed ID: 34500045
[No Abstract] [Full Text] [Related]
18. Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1.
Pichler M; Steyrer J
ESMO Open; 2021 Aug; 6(4):100198. PubMed ID: 34175674
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Powles T; Albiges L; Bex A; Comperat E; Grünwald V; Kanesvaran R; Kitamura H; McKay R; Porta C; Procopio G; Schmidinger M; Suarez C; Teoh J; de Velasco G; Young M; Gillessen S;
Ann Oncol; 2024 May; ():. PubMed ID: 38788900
[No Abstract] [Full Text] [Related]
20. Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Le Rhun E; Weller M; van den Bent M; Brandsma D; Furtner J; Rudà R; Schadendorf D; Seoane J; Tonn JC; Wesseling P; Wick W; Minniti G; Peters S; Curigliano G; Preusser M;
ESMO Open; 2023 Oct; 8(5):101624. PubMed ID: 37863528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
